Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XZH | ISIN: FR0012882389 | Ticker-Symbol: PHF
Frankfurt
02.07.25 | 15:29
46,350 Euro
-4,14 % -2,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
EQUASENS SA Chart 1 Jahr
5-Tage-Chart
EQUASENS SA 5-Tage-Chart
RealtimeGeldBriefZeit
45,70048,80002.07.
GlobeNewswire (Europe)
57 Leser
Artikel bewerten:
(0)

Equasens: General meeting - Results of the votes

Villers-lès-Nancy, 1st July 2025 - 07:00 p.m. (CET)

PRESS RELEASE

RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING
OF 25 JUNE 2025

Number of shares comprising the share capital: 15,174,125

Number of shares with voting rights: 14,830,415

Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,173,125

That means a quorum of 88.83% of the 14,830,415 shares with voting rights: the Ordinary Annual General Meeting was able to deliberate.

The Ordinary Annual General Meeting was held on Wednesday, 25 June 2025 at 5:30 p.m. at the Company's headquarters and approved the separate parent company and consolidated financial statements for the 2024 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:

Resolutions

Results of the votes

  • RESOLUTION ONE
Approval of the annual financial statements
Resolution adopted by:
  • 13,170,684 votes in favour
  • 0 vote against
  • 2,441 abstentions
  • RESOLUTION TWO
Discharge of directors and discharge of the Statutory Auditors for the performance of their engagement
Resolution adopted by:
  • 12,831,312 votes in favour
  • 339,266 votes against
  • 2,547 abstentions
  • RESOLUTION THREE
    Approval of the consolidated financial statements
Resolution adopted by:
  • 13,170,684 votes in favour
  • 0 vote against
  • 2,441 abstentions
  • RESOLUTION FOUR
Appropriation of earnings, setting the dividend
Resolution adopted by:
  • 13,138,631 votes in favour
  • 34,494 votes against
  • 0 abstention
  • RESOLUTION FIVE
Agreements and commitments governed by Articles L. 225-38 of the French Commercial Code
Resolution adopted by (*):
  • 13,101,211 votes in favour
  • 59,549 votes against
  • 12,365 abstentions
  • RESOLUTION SIX
Approval of the information on the compensation of corporate officers paid in or granted for fiscal 2024 and mentioned in Article L. 22-10-9 of the French Commercial Code
Resolution adopted by:
  • 12,507,815 votes in favour
  • 665,242 votes against
  • 68 abstentions
  • RESOLUTION SEVEN
Approval of the components of compensation paid in 2024 to Mr. Thierry CHAPUSOT, Chairman of the Board of Directors
Resolution adopted by:
  • 13,115,547 votes in favour
  • 57,510 votes against
  • 68 abstentions
  • RESOLUTION EIGHT
Approval of the components of compensation paid in 2024 to Mr. Denis SUPPLISSON, Chief Executive Officer
Resolution adopted by:
  • 10,782,118 votes in favour
  • 2,390,939 votes against
  • 68 abstentions
  • RESOLUTION NINE
Approval of the components of compensation paid in 2024 to Mr. Grégoire DE ROTALIER, Deputy CEO
Resolution adopted by:
  • 10,782,118 votes in favour
  • 2,390,939 votes against
  • 68 abstentions
  • RESOLUTION TEN
Approval of the components of compensation paid in 2024 to Mr. Damien VALICON, Deputy CEO (non-Board member), as from 01/04/2024
Resolution adopted by:
  • 10,762,253 votes in favour
  • 2,410,804 votes against
  • 68 abstentions
  • RESOLUTION ELEVEN
Approval of the compensation policy for Mr. Thierry CHAPUSOT, Chairman of the Board of Directors, for 2025
Resolution adopted by:
  • 13,115,547 votes in favour
  • 57,510 votes against
  • 68 abstentions
  • RESOLUTION TWELVE
Approval of the compensation policy for Mr. Denis SUPPLISSON, Chief Executive Officer, for 2025
Resolution adopted by:
  • 10,545,572 votes in favour
  • 2,454,875 votes against
  • 172,678 abstentions
  • RESOLUTION THIRTEEN
Approval of the compensation policy for Mr. Grégoire de ROTALIER, Deputy Chief Executive Officer, for 2025
Resolution adopted by:
  • 10,537,207 votes in favour
  • 2,463,240 votes against
  • 172,678 abstentions
  • RESOLUTION FOURTEEN
Approval of the compensation policy for Mr. Damien VALICON, Deputy Chief Executive Officer, for 2025
Resolution adopted by:
  • 10,537,207 votes in favour
  • 2,463,240 votes against
  • 172,678 abstentions
  • RESOLUTION FIFTEEN
Approval of the compensation policy for Directors
Resolution adopted by:
  • 13,127,845 votes in favour
  • 45,212 votes against
  • 68 abstentions
  • RESOLUTION SIXTEEN
Setting total annual compensation for Directors for 2025
Resolution adopted by:
  • 13,127,845 votes in favour
  • 45,212 votes against
  • 68 abstentions
  • RESOLUTION SEVENTEEN
Authorisation by the Company to repurchase its own shares
Resolution adopted by:
  • 11,297,178 votes in favour
  • 1,875,947 votes against
  • 0 abstention
  • RESOLUTION EIGHTEEN
Powers for formalities
Resolution adopted by:
  • 13,173,125 votes in favour
  • 0 vote against
  • 0 abstention

(*) After deduction of excluded voting rights

Upcoming financial communications

  • 31 July 2025: Q2 2025 revenue - After the close of trading
  • 26 September 2025: H1 2025 results: 26 September 2025

About Equasens Group

Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.300 people across Europe.
Equasens Group's specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.
And reflecting the spirit of its tagline "Technology for a More Human Experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.

Listed on Euronext Paris - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service ("Service à Réglement Différé" - SRD) and equity savings accounts invested in small and mid-caps (PEA-PME).
ISIN: FR 0012882389 - Ticker Code: EQS

Get all the news about Equasens Group www.equasens.com and on LinkedIn

CONTACTS

EQUASENS Group
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 - frederique.schmidt@equasens.com

Financial communications agency:
FIN'EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 - i.aprile@finextenso.fr


© 2025 GlobeNewswire (Europe)
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.